Skip to main content
. 2020 Aug 28;104(1):27–57. doi: 10.1093/biolre/ioaa152

Table 1.

Human pregnancy complications.

Pregnancy complication Percent impact Current means of identification Underlying pathology
PE • 3–5% of pregnancies [177] • Accounts for 14% of pregnancy-associated maternal deaths [177, 178] • High blood pressure [354] • Proteinuria [354] • Possible renal, liver, pulmonary, and neurological sequelae [177] • PE is sometimes split into two categories with separate pathologies: early onset PE (EPE), <34 weeks gestation and late onset PE (LPE), ≥34 weeks gestation • Abnormal trophoblast invasion of the maternal decidua and incomplete remodeling of maternal spiral arteries leads to placental ischemia and a pro-inflammatory environment [179] • Often associated with IUGR [177] • EPE: considered a fetal disease with associated placental dysfunction • LPE: a maternal disorder; placenta usually functions properly and is associated with better maternal and fetal outcomes, at least in part based on later delivery (obviating prematurity as a contributor to pathology) [180]
EPL • 15–25% of all clinical pregnancies [181–183] • Fetal chromosomal abnormalities are the major cause [184, 185]; however, in cases of normal fetal karyotype, the cause is typically unknown [186–189]
RPL • ~1% of all women [190] • RPL is identified by two or more clinical EPLs (pregnancy diagnosis based on ultrasound or tissue/pathology, not chorionic gonadotropin detection alone) [181, 191] • When uterine anatomical anomalies, genetic factors, antiphospholipid syndrome, or hormonal pathologies are ruled out, more than 50% of patients suffer from unexplained RPL [181, 182, 192]
FGR/IUGR • 10% of pregnancies [193] • Ultrasound-estimated fetal weight less than the 10th percentile for that gestational age or a fetus at <10th percentile at birth [193] • Origins stem from errors in early placental development [194] • Caused by placental insufficiency, genetic syndromes, maternal malnutrition, multiple gestation, teratogens, and oxygen deprivation [134, 195]
• Maternal vascular malperfusion is considered the leading cause of pathology in FGR placentas and can be accompanied with placental hypoplasia, infarction, and hemorrhage [196]
• Often associated with PE [177]
Pre-GD • ~7% of all pregnancies [11] • High risk of maternal morbidity [197] • Having type 1 or type 2 diabetes prior to start of pregnancy • Hyperglycemia can impair and disrupt fetal organ development [8] • Placentas from women with diabetes generally have greater surface area, Hofbauer cells, vasculature, and diffusion distance [199]
GDM • Leading cause of fetal macrosomia [198] • Glucose intolerance and insulin resistance development during pregnancy • Placental pathologies include chorionic villus immaturity, high villus density, stromal edema, thicker than average collagen fibers, and diffuse villous stromal calcifications [17], potentially impacting function
PTB • ~11% of all pregnancies [170] • 75% of perinatal mortality is due to PTB [200] • Birth before 37 weeks of gestation [170] • Oxidative stress and inflammation leading to early rupture of membranes are known to be leading causes of PTB, in addition to retroplacental abruption, chronic villitis, and twin gestations [201] • Other causes hypothesized to be involved include vertically transmitted infections, maternal environmental stress, and intra-amniotic inflammation [170, 200]